Spectrum of Microbial Etiology of Community-Acquired Pneumonia in Hospitalized Patients: Implications for Selection of the Population for Enrollment in Clinical Trials

The title of this article implies that knowledge of the etiological pathogen may be useful in selection of patients for clinical trials for community-acquired pneumonia (CAP). However, this remains to be seen. The clinical course of a patient with CAP admitted to the hospital but not to the intensive care unit depends on a number of variables, including the patient, the pathogen, and the hospital itself. The site-of-care decision can be based …